Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Hair loss in balding individuals is linked to changes in specific hair growth-related genes.

Jagged-1 in skin Tregs is crucial for timely wound healing by recruiting specific immune cells.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

STAT5 activation is crucial for starting the hair growth phase.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.

Forsythiasides have multiple health benefits but may cause pseudoallergic reactions, and more research is needed.

Aging slows wound healing due to weaker cells and immune response.

Medicinal herbs might treat hair loss by affecting genes and pathways related to lipid and glycerophospholipid metabolism.

Natural products like plant extracts can help promote hair growth and could be used to treat hair loss.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.